| For: | Si XY, Merlin D, Xiao B. Recent advances in orally administered cell-specific nanotherapeutics for inflammatory bowel disease. World J Gastroenterol 2016; 22(34): 7718-7726 [PMID: 27678353 DOI: 10.3748/wjg.v22.i34.7718] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i34/7718.htm |
| Number | Citing Articles |
| 1 |
Miao Zheng, Haifu Jia, Manyan Qiu, Xinyan Yang, Xianlong Zhang, Qianyu Zhao, Yujun Jiang. Recent advances in stimuli-responsive oral delivery systems for controlled release of probiotics: A review. Food Research International 2025; 220 doi: 10.1016/j.foodres.2025.117132
|
| 2 |
Bojan Čalija, Jela Milić. Targeted delivery of anti-inflammatory drugs in lower parts of gastrointestinal tract: Conventional and novel approaches. Arhiv za farmaciju 2017; 67(3) doi: 10.5937/arhfarm1702124C
|
| 3 |
Michal Caspi, Amnon Wittenstein, Michal Kazelnik, Yarden Shor-Nareznoy, Rina Rosin-Arbesfeld. Therapeutic targeting of the oncogenic Wnt signaling pathway for treating colorectal cancer and other colonic disorders. Advanced Drug Delivery Reviews 2021; 169 doi: 10.1016/j.addr.2020.12.010
|
| 4 |
Shivangi Sharma, Murari Lal Soni, Hero Khan Pathan, Rajeev Sharma. Ophthalmic Drug Delivery. 2026; doi: 10.1016/B978-0-443-33781-9.00009-5
|
| 5 |
Mohammed Tayeb Oucif Khaled, Abdelmalekd Zaater, Ilham Ben Amor, Soumeia Zeghoud, Asma Ben Amor, Hadia Hemmami, Ali Alnazza Alhamad. Drug delivery methods based on nanotechnology for the treatment of eye diseases. Annals of Medicine & Surgery 2023; 85(12) doi: 10.1097/MS9.0000000000001399
|
| 6 |
Amandeep Singh, Kirandeep Kaur, Uttam Kumar Mandal, Raj Kumar Narang. Nanoparticles as Budding Trends in Colon Drug Delivery for the Management of Ulcerative Colitis. Current Nanomedicine 2020; 10(3) doi: 10.2174/2468187310999200621200615
|
| 7 |
Chandrakantsing Pardeshi, Ganesh Shevalkar, Mahesh Umbarkar, Dipak Bari, Kamalesh Mali, Sameer Lakade, Mónica García. Advanced Drug Delivery Systems for Colonic Disorders. 2024; doi: 10.1016/B978-0-443-14044-0.00014-4
|
| 8 |
Dinakar Swastha, Nambolan Varsha, Suresh Aravind, Kavassery Balasubramanian Samyuktha, Muruganandam Mohaneswari Yokesh, Akshad Balde, Bakthavatchalam Loganathan Ayilya, Soottawat Benjakul, Se-Kwon Kim, Rasool Abdul Nazeer. Alginate-based drug carrier systems to target inflammatory bowel disease: A review. International Journal of Biological Macromolecules 2023; 244 doi: 10.1016/j.ijbiomac.2023.125472
|
| 9 |
Prasad Minakshi, Rajesh Kumar, Mayukh Ghosh, Basanti Brar, Manju Barnela, Preeti Lakhani. Application of Polymeric Nano-Materials in Management of Inflammatory Bowel Disease. Current Topics in Medicinal Chemistry 2020; 20(11) doi: 10.2174/1568026620666200320113322
|
| 10 |
Vijay Kumar Singh, Veena Singh, Vishal Tyagi. Colon Cancer Diagnosis and Therapy. 2021; doi: 10.1007/978-3-030-64668-4_14
|
| 11 |
Yanhong Wu, Shangyong Li, Mengfei Jin, Dandan Li, Zihan Zhou, Haiqing Hou, Yantao Han. Preparation of MSZ Hydrogel and Its Treatment of Colitis. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.706401
|
| 12 |
Amusa S. Adebayo, Kafilat Agbaje, Simeon K. Adesina, Oluwabukunmi Olajubutu. Colorectal Cancer: Disease Process, Current Treatment Options, and Future Perspectives. Pharmaceutics 2023; 15(11) doi: 10.3390/pharmaceutics15112620
|
| 13 |
M. Khotimchenko. Pectin polymers for colon-targeted antitumor drug delivery. International Journal of Biological Macromolecules 2020; 158 doi: 10.1016/j.ijbiomac.2020.05.002
|
| 14 |
Yunyue Zhang, Maya Thanou, Driton Vllasaliu. Exploiting disease-induced changes for targeted oral delivery of biologics and nanomedicines in inflammatory bowel disease. European Journal of Pharmaceutics and Biopharmaceutics 2020; 155 doi: 10.1016/j.ejpb.2020.08.017
|
| 15 |
Mahmood Barani, Mahwash Mukhtar, Abbas Rahdar, Saman Sargazi, Sadanand Pandey, Misook Kang. Recent Advances in Nanotechnology-Based Diagnosis and Treatments of Human Osteosarcoma. Biosensors 2021; 11(2) doi: 10.3390/bios11020055
|
| 16 |
Abinaya Shanmugavadivu, Sundaravadhanan Lekhavadhani, P J Miranda, Nagarajan Selvamurugan. Current approaches in tissue engineering-based nanotherapeutics for osteosarcoma treatment. Biomedical Materials 2024; 19(2) doi: 10.1088/1748-605X/ad270b
|
| 17 |
ROZHAN ARIF MUHAMMED, SAYA MOHAMMED, SHARAD VISHT, ALI OMAR YASSEN. A REVIEW ON DEVELOPMENT OF COLON TARGETED DRUG DELIVERY SYSTEM. International Journal of Applied Pharmaceutics 2024; doi: 10.22159/ijap.2024v16i2.49293
|
| 18 |
C. Sarath Chandran, Krishnameera Sajayan, Jeeva C. Soman, P.K. Anjana, K.K. Swathy, A.S. Vishnu, Shijina Kappally. Advanced Drug Delivery Systems for Colonic Disorders. 2024; doi: 10.1016/B978-0-443-14044-0.00001-6
|
| 19 |
Mengchi Sun, Weiyue Ban, Hao Ling, Xiang Yu, Zhonggui He, Qikun Jiang, Jin Sun. Emerging nanomedicine and prodrug delivery strategies for the treatment of inflammatory bowel disease. Chinese Chemical Letters 2022; 33(10) doi: 10.1016/j.cclet.2022.03.061
|
| 20 |
Rania E. El-Desoky Mohamady, Sania K. Elwia, Sahar M. Abo El Wafa, Mona Ataya Mohamed. Effect of mesenchymal stem cells derived exosomes and green tea polyphenols on acetic acid induced ulcerative colitis in adult male albino rats. Ultrastructural Pathology 2022; 46(2) doi: 10.1080/01913123.2022.2039825
|
| 21 |
Shuangquan Gou, Yamei Huang, Junsik Sung, Bo Xiao, Didier Merlin. Silk fibroin-based Nanotherapeutics: Application in the Treatment of Colonic Diseases. Nanomedicine 2019; 14(17) doi: 10.2217/nnm-2019-0058
|
| 22 |
Bo Xiao, Qiubing Chen, Zhan Zhang, Lixin Wang, Yuejun Kang, Timothy Denning, Didier Merlin. TNFα gene silencing mediated by orally targeted nanoparticles combined with interleukin-22 for synergistic combination therapy of ulcerative colitis. Journal of Controlled Release 2018; 287 doi: 10.1016/j.jconrel.2018.08.021
|
| 23 |
Rabia Arshad, Mahmood Barani, Abbas Rahdar, Saman Sargazi, Magali Cucchiarini, Sadanand Pandey, Misook Kang. Multi-Functionalized Nanomaterials and Nanoparticles for Diagnosis and Treatment of Retinoblastoma. Biosensors 2021; 11(4) doi: 10.3390/bios11040097
|
| 24 |
Mahmood Barani, Abbas Rahdar, Saman Sargazi, Mohammad Sadegh Amiri, Preetam Kumar Sharma, Nikhil Bhalla. Nanotechnology for inflammatory bowel disease management: Detection, imaging and treatment. Sensing and Bio-Sensing Research 2021; 32 doi: 10.1016/j.sbsr.2021.100417
|
| 25 |
Kristina Zlatina, Sebastian P. Galuska. The N-glycans of lactoferrin: more than just a sweet decoration. Biochemistry and Cell Biology 2021; 99(1) doi: 10.1139/bcb-2020-0106
|
| 26 |
Jyoti Singh, Ashutosh Solanki, Gaurav Singh Sikarwar, Niraj Kumar Singh. Advances in Colon-targeted Drug Delivery Systems: Innovative Strategies for Treating Colonic Disorders and Prospects for the Future. Current Pharmaceutical Biotechnology 2025; 26(16) doi: 10.2174/0113892010323922240924053921
|
| 27 |
Mehrdad Afarid, Shirin Mahmoodi, Roghayyeh Baghban. Recent achievements in nano-based technologies for ocular disease diagnosis and treatment, review and update. Journal of Nanobiotechnology 2022; 20(1) doi: 10.1186/s12951-022-01567-7
|
| 28 |
Rajesh Singh Pawar, Shweta Kumar, Sulakshana Pawar. Multifunctional Nanocomposites for Targeted Drug Delivery in Cancer Therapy. 2024; doi: 10.1016/B978-0-323-95303-0.00001-0
|
| 29 |
Tivadar Feczkó. Polymeric nanotherapeutics acting at special regions of body. Journal of Drug Delivery Science and Technology 2021; 64 doi: 10.1016/j.jddst.2021.102597
|
| 30 |
Muhammad Naeem, Uzma Azeem Awan, Fazli Subhan, Jiafu Cao, Shwe Phyu Hlaing, Juho Lee, Eunok Im, Yunjin Jung, Jin-Wook Yoo. Advances in colon-targeted nano-drug delivery systems: challenges and solutions. Archives of Pharmacal Research 2020; 43(1) doi: 10.1007/s12272-020-01219-0
|
| 31 |
Marcel Vetter, Markus F. Neurath. Emerging oral targeted therapies in inflammatory bowel diseases: opportunities and challenges. Therapeutic Advances in Gastroenterology 2017; 10(10) doi: 10.1177/1756283X17727388
|
| 32 |
Lauren J. Mohan, Jacqueline S. Daly, Barbara M. Ryan, Zebunnissa Ramtoola. The future of nanomedicine in optimising the treatment of inflammatory bowel disease. Scandinavian Journal of Gastroenterology 2019; 54(1) doi: 10.1080/00365521.2018.1563805
|
| 33 |
Lauren J. Mohan, Lauren McDonald, Jacqueline S. Daly, Zebunnissa Ramtoola. Optimising PLGA-PEG Nanoparticle Size and Distribution for Enhanced Drug Targeting to the Inflamed Intestinal Barrier. Pharmaceutics 2020; 12(11) doi: 10.3390/pharmaceutics12111114
|
| 34 |
Muhammad Bilal, Leonardo Vieira Nunes, Marco Thúlio Saviatto Duarte, Luiz Fernando Romanholo Ferreira, Renato Nery Soriano, Hafiz M. N. Iqbal. Exploitation of Marine-Derived Robust Biological Molecules to Manage Inflammatory Bowel Disease. Marine Drugs 2021; 19(4) doi: 10.3390/md19040196
|
| 35 |
Rahul Mittal, Amit P. Patel, Vasanti M. Jhaveri, Sae-In S. Kay, Luca H. Debs, James M. Parrish, Debbie R. Pan, Desiree Nguyen, Jeenu Mittal, Rahul Dev Jayant. Recent advancements in nanoparticle based drug delivery for gastrointestinal disorders. Expert Opinion on Drug Delivery 2018; 15(3) doi: 10.1080/17425247.2018.1420055
|
| 36 |
Yilin Guo, Shiyu Zong, Yiqiong Pu, Benliang Xu, Tong Zhang, Bing Wang. Advances in Pharmaceutical Strategies Enhancing the Efficiencies of Oral Colon-Targeted Delivery Systems in Inflammatory Bowel Disease. Molecules 2018; 23(7) doi: 10.3390/molecules23071622
|
| 37 |
Zhishu Li, Qiongqiong Yang. Biomarker-responsive nanomaterials for precision theranostics in inflammatory bowel disease. Coordination Chemistry Reviews 2026; 552 doi: 10.1016/j.ccr.2025.217467
|
| 38 |
Hongtao Zhu, Zhi-Jing Ni, Qian Zhong, Wei Wang, Ya-Jing An, Kiran Thakur, Jian-Guo Zhang, Zhong-Li Chen, Zhao-Jun Wei. Sericin peptides alleviate dextran sulfate-induced ulcerative colitis symptoms by modulating the Th17 cell differentiation pathway in C57BL/6 mice. Food Bioscience 2024; 62 doi: 10.1016/j.fbio.2024.105555
|
| 39 |
Yamei Huang, Brandon S. B. Canup, Shuangquan Gou, Nanxi Chen, Fangyin Dai, Bo Xiao, Changming Li. Oral nanotherapeutics with enhanced mucus penetration and ROS-responsive drug release capacities for delivery of curcumin to colitis tissues. Journal of Materials Chemistry B 2021; 9(6) doi: 10.1039/D0TB02092C
|
| 40 |
Phool Chandra, Manav Ruhela, Prashant Kumar, Mayur Porwal, Anurag Verma, Himanshu Sharma, Neetu Sachan. Nanotechnology-based Approaches for Targeted Drug Delivery to the Small Intestine: Advancements and Challenges. Current Pharmaceutical Design 2025; 31(24) doi: 10.2174/0113816128347722250109042022
|
| 41 |
Sang Hoon Lee, Rajiv Bajracharya, Jeong Youn Min, Ji-Won Han, Byeong Ju Park, Hyo-Kyung Han. Strategic Approaches for Colon Targeted Drug Delivery: An Overview of Recent Advancements. Pharmaceutics 2020; 12(1) doi: 10.3390/pharmaceutics12010068
|
| 42 |
Fanny Giron, Anna Pastó, Ennio Tasciotti, Bincy P Abraham. Nanotechnology in the Treatment of Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2019; 25(12) doi: 10.1093/ibd/izz205
|